Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
We're thrilled to welcome Doug Love, the dynamic President and Chief Executive Officer of Annexon Biosciences. With a storied career that spans over two decades in biotech, Douglas brings a wealth of experience from his transformative roles at companies like Elan Pharmaceuticals and Genentech.
At Annexon, he's at the helm of pioneering treatments for classical complement-mediated disorders, driving forward innovations that promise to change the lives of patients around the globe.
Join us as Douglas shares his journey through the biotech landscape, the challenges and achievements of leading Annexon, and his vision for the future of medical treatments.
Enjoy and stay tuned.
